David has 25 years of experience in Management of medical start-Up companies and Investment companies. Previously he was the CEO of Dentack Implants and led the company from R&D to commercialization. He also served as CEO of Dyn-Bioshaf (diagnostic) and Darly Pharmaceuticals. David managed Dyn Holdings, an incubator for medical ventures and was the CEO of DCL, an investment company listed in TASE with 13 startup companies under management.
David holds B.Sc. in Economic & Management, Industrial Engineering Faculty, Technion, Haifa, Israel.